Prospeo
Hero Section BackgroundHero Section Background
ReCode Therapeutics

ReCode Therapeutics Revenue

Biotechnology ResearchFlag of USMenlo Park, California & Durham, United States51-100 Employees

$

ReCode Therapeutics revenue & valuation

Annual revenue$16,000,000
Revenue per employee$193,000
Estimated valuation?$51,200,000
Total funding$65,000,000

Key Contacts at ReCode Therapeutics

Flag of US

Shehnaaz Suliman

President & Chief Executive Officer

Flag of US

Alan Colowick

Member Board Of Directors

Flag of US

Dejuan L. Owens

Associate Director, Supply Chain

Flag of US

Joseph Chen

Director, Preclinical Translational Biology

Flag of US

Sakya Mohapatra

Senior Director, Formulation And Process Development

Flag of US

Trisha Millican

Member Board Of Directors

Flag of US

Stacy Sherman

Director Program Management

Flag of US

Vishal Desai

Sr. Director, It

Flag of US

Diana Dong

Director, Clinical Project Management

Flag of US

Anna Martinez

Senior Director / Site Head

Company overview

HeadquartersMenlo Park, California & Durham, United States
Phone number+14085851700
Website
NAICS541714
Keywords
Biotechnology, Cystic Fibrosis, Genetic Medicines, Genetic Respiratory Disease, Non-Viral Lipid Nanoparticles, Primary Ciliary Dyskinesia, Rna Therapies
Founded2015
Employees51-100
Socials

ReCode Therapeutics Email Formats

ReCode Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@recodetx.com), used 68.7% of the time.

FormatExamplePercentage
{first initial}{last name}
jdoe@recodetx.com
68.7%
{first name}{last name}
johndoe@recodetx.com
23.9%
{last name}{last name}
doedoe@recodetx.com
7.5%

About ReCode Therapeutics

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry
Senior
Director

Employees by Department

ReCode Therapeutics has 33 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore ReCode Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2023-10-195$50,000,000
2024-12-181$15,000,000

Funding Insights

$65,000,000

Total funding amount

$15,000,000

Most recent funding amount

2

Number of funding rounds

ReCode Therapeutics Tech Stack

Discover the technologies and tools that power ReCode Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Underscore.js

Underscore.js

JavaScript libraries

WPForms

WPForms

Form builders

Swiper

Swiper

JavaScript libraries

PubSubJS

PubSubJS

JavaScript libraries

jQuery UI

jQuery UI

JavaScript libraries

Animate.css

Animate.css

UI frameworks

Elementor

Elementor

Page builders

Microsoft 365

Microsoft 365

Email

jQuery Migrate

jQuery Migrate

JavaScript libraries

Cloudflare

Cloudflare

CDN

MonsterInsights

MonsterInsights

Analytics

Twitter Emoji

Font scripts

Frequently asked questions

ReCode Therapeutics is located in Menlo Park, California & Durham, US.
You can reach ReCode Therapeutics at +14085851700.
ReCode Therapeutics generates an estimated annual revenue of $16,000,000. This revenue figure reflects the company's market position and business performance in its industry.
ReCode Therapeutics has an estimated valuation of $51,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
ReCode Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.
ReCode Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.
ReCode Therapeutics has raised a total of $65,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles